Andere talen Bio-Rad Laboratories, Inc.

Aandelen

BIO

US0905722072

Medische apparatuur, benodigdheden & distributie

Beurs gesloten - Nyse Andere beurzen 22:00:02 24-06-2025			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
237,91 ^USD	+1,01%		+3,23%	-27,58%

05/06	Amerikaanse bedrijven kondigen ontslagen aan om kosten te besparen	RE
27/05	Genetic Analysis vermindert het nettoverlies	FW

Andere talen

US companies announce layoffs to cut costs	05/06
US companies announce layoffs to cut costs	05/06
Bio-Rad’s Management to Host Investor Meetings During Jefferies Global Healthcare Conference	29/05
US companies announce layoffs to cut costs	22/05
Bio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global Healthcare Conference	12/05
Bio-Rad Laboratories Q1 Adjusted Earnings Rise, Revenue Falls	02/05
Bio-Rad Laboratories Expects 2025 Non-GAAP Revenue to Range From 1% Drop to 1.5% Growth Vs. Prior Est 1.5% to 3.5% Gain	01/05
Bio-Rad Reports First-Quarter 2025 Financial Results	01/05
Bio-Rad: Q1 Earnings Snapshot	01/05
Tranche Update on Bio-Rad Laboratories, Inc.'s Equity Buyback Plan announced on July 20, 2023.	01/05
Bio-Rad Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	01/05
Earnings Flash (BIO) Bio-Rad Laboratories Reports Q1 Revenue $585.4M, vs. FactSet Est of $573.3M	01/05
Earnings Flash (BIO.B) Bio-Rad Laboratories Reports Q1 Adjusted EPS $2.54, vs. FactSet Est of $1.82	01/05
Geneoscopy, Inc. announced that it has received $120.850521 million in funding from a group of investors	01/05
Declaration of Voting Results by Bio-Rad Laboratories	25/04
Biodesix, Inc. and Bio-Rad Laboratories, Inc. Submits New Research Findings from Friends of Cancer Research's ctMoniTR Project	23/04
Fivespan Partners LP Provides Information to the Shareholder of Qiagen NV	16/04
Bio-Rad To Report First Quarter 2025 Financial Results On Thursday, May 1, 2025	15/04
Bio-Rad to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025	15/04
Bio Rad Laboratories : 2024 Annual Report (Annual Report)	26/03
Bio-Rad Laboratories, Inc Company Receives a Shareholder Proposal from John Chevedden	26/03
US companies announce layoffs to cut costs	19/03
US companies announce layoffs to cut costs	03/03
AIMA Laboratories Inc. announced that it has received $5 million in funding from Bio-Rad Laboratories, Inc., Impact America Fund, SOSV Investments LLC, Capital Angel Network, Gaingels Management, LLC	25/02
Sartorius-Vorzüge und -Stämme schwach - Gerücht über Verkäufe	17/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripten Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Bio-Rad Laboratories, Inc.

Aandelen

BIO

US0905722072

Medische apparatuur, benodigdheden & distributie

Andere talen

Filters